296 posters, 7 videos, 13 audios, 14 topics, 10 sessions, 1,019 authors, 259 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
RCOphth Annual Congress 2026
18 - 21 May, 2026 | Manchester Central, Manchester
P130
12-month real-world outcomes of switching to aflibercept 8 mg in suboptimal responders with neovascular Age-Related Macular Degeneration (nARMD)
Poster Presenter
Authors
Georgios Papadakis, Riyaa Sahare, Hamza Mohammed Sultan, Ian De Silva, Rossella Anzidei, Ikenna Ahuche, Urom Chukwunonso, Somain Verma, Vasileios Konidaris
Affiliations
1Medical Retina, Ophthalmology, University Hospitals of Leicester NHS Trust, Leicester UK, 3University of Leicester, Leicester, England, UK, 2Ophthalmology, University Hospitals of Leicester NHS Trust, Leicester, England, UK, 2Ophthalmology, University Hospitals of Leicester NHS Trust, Leicester UK
Part of Topic
Medical retina
neovascular AMD, aflibercept 8 mg, anti-VEGF switching, treatment interval extension, treat-and-extend, real-world evidence (RWE), real-world data (RWD), OCT, central retinal thickness (CRT)